Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Egevad

Showing results (181-190 of 379) with videos related to

Pageof 38
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 26, 2019
PD-L1 expression and deficient mismatch repair in ductal adenocarcinoma of the prostateClaes Lindh, Lorand Kis, Brett Delahunt, et al.
Plos One|September 3, 2010
Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4Lina Thors, Anders Bergh, Emma Persson, et al.
Virchows Archiv : an International Journal of Pathology|July 26, 2014
Immunohistochemical profile of ductal adenocarcinoma of the prostateAmanda H Seipel, Hemamali Samaratunga, Brett Delahunt, et al.
Plos One|September 13, 2014
ErbB2 receptor immunoreactivity in prostate cancer: relationship to the androgen receptor, disease severity at diagnosis and disease outcomePeter Hammarsten, Johanna Winther, Stina H Rudolfsson, et al.
Pathology|June 10, 2021
The emerging role of artificial intelligence in the reporting of prostate pathologyLars Egevad, Brett Delahunt, Hemamali Samaratunga, et al.
Proteomics|May 14, 2005
Differential protein expression in anatomical zones of the prostateHelena Lexander, Bo Franzén, Daniel Hirschberg, et al.
British Journal of Cancer|October 9, 2018
A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosisElin Sjöberg, Magnus Frödin, John Lövrot, et al.
Vaccine|May 24, 2022
Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding?Axel Möller, Klaus Schwamborn, Adrian Spillmann, et al.
BJU International|April 25, 2025
Positive surgical margin and oncological outcomes after robot-assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groupsAnna Hagman, Anna Lantz, David Grannas, et al.
BJU International|February 27, 2016
Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012Daniela Danneman, Linda Drevin, Brett Delahunt, et al.
Pageof 38

Showing results (181-190 of 379) with videos related to

Sort By:
Pageof 38
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 26, 2019
PD-L1 expression and deficient mismatch repair in ductal adenocarcinoma of the prostateClaes Lindh, Lorand Kis, Brett Delahunt, et al.
Plos One|September 3, 2010
Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4Lina Thors, Anders Bergh, Emma Persson, et al.
Virchows Archiv : an International Journal of Pathology|July 26, 2014
Immunohistochemical profile of ductal adenocarcinoma of the prostateAmanda H Seipel, Hemamali Samaratunga, Brett Delahunt, et al.
Plos One|September 13, 2014
ErbB2 receptor immunoreactivity in prostate cancer: relationship to the androgen receptor, disease severity at diagnosis and disease outcomePeter Hammarsten, Johanna Winther, Stina H Rudolfsson, et al.
Pathology|June 10, 2021
The emerging role of artificial intelligence in the reporting of prostate pathologyLars Egevad, Brett Delahunt, Hemamali Samaratunga, et al.
Proteomics|May 14, 2005
Differential protein expression in anatomical zones of the prostateHelena Lexander, Bo Franzén, Daniel Hirschberg, et al.
British Journal of Cancer|October 9, 2018
A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosisElin Sjöberg, Magnus Frödin, John Lövrot, et al.
Vaccine|May 24, 2022
Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding?Axel Möller, Klaus Schwamborn, Adrian Spillmann, et al.
BJU International|April 25, 2025
Positive surgical margin and oncological outcomes after robot-assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groupsAnna Hagman, Anna Lantz, David Grannas, et al.
BJU International|February 27, 2016
Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012Daniela Danneman, Linda Drevin, Brett Delahunt, et al.
Pageof 38